25
Participants
Start Date
May 31, 2008
Primary Completion Date
June 30, 2009
Study Completion Date
June 30, 2009
WN-80E
Three injections of the study vaccine \[Low Dose of WN-80E API (5 µg) + Alhydrogel (3.5 mg)\] given one month apart
WN-80E
Three injections of the study vaccine \[Medium Dose WN-80E API (15 µg) + Alhydrogel (3.5 mg)\] given one month apart
WN-80E
Three injections of the study vaccine \[High Dose WN-80E API (50 µg) + Alhydrogel (3.5 mg)\] given one month apart
WN-80E
Three injections of the study vaccine \[High Dose WN-80E API (50 µg)\] given one month apart
Covance Clinical Research Unit, Honolulu
Lead Sponsor
Hawaii Biotech, Inc.
INDUSTRY